Publications by authors named "Muhanad Abu Elhija"
Background: The treat-to-target approach was recently adopted for psoriatic arthritis (PsA) management.
Objective: To assess the implementation of the "treat-to-target" (T2T) concept in daily management of PsA by use of composite scores of disease activity versus clinical judgement alone.
Methods: A total of 117 PsA patients from a longitudinal PsA cohort were enrolled consecutively in the study during each patient's first clinic visit during 2016-2017.
Article Synopsis
- Some vaccines, including those for SARS-CoV-2, can trigger or worsen immune-mediated diseases (IMDs) due to their unique mechanisms of action involving TLR agonism.
- A study evaluated 27 cases of new-onset or flare-up of IMDs within 28 days of receiving SARS-CoV-2 vaccines across five major medical centers in Israel, the UK, and the USA, with most cases linked to the BNT-162b2 vaccine.
- The majority of cases were mild to moderate in severity, with notable recovery in over 80% of patients, often with corticosteroid treatment, and a large number of IMD occurrences could not be directly linked to the specific vaccine administered.